Rhonda Kitzler

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial

C. Hofmeister, A. Krishnan, W. Wachsman, 2021, Frontiers in Immunology.

Atorvastatin for the Prophylaxis of Acute Graft vs. Host Disease (GVHD) in Patients Undergoing HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation (HSCT)

C. Hofmeister, R. Garzon, G. Lozanski, 2016 .

Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).

K. Coombes, C. Hofmeister, R. Garzon, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.

C. Hofmeister, G. Lozanski, L. Andritsos, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3

M. Kris, V. Rusch, I. Wistuba, 2019, Journal of Thoracic Oncology.